biomedicina slovenica

pr=Coleman : 31

  1. Allemani Claudia; Matsuda Tomohiro; Di Carlo Veronica; Harewood Rhea; Matz Melissa; Nikšić Maja; Bonaventure Audrey; Valkov Mikhail; Estève Jacques; Coleman Michel P.; Primic-Žakelj Maja; Zadnik Vesna
    Global surveillance of trends in cancer survival 2000-14 (CONCORD-3)
    2018 ►
  2. Launoy Guy; Coleman Michel P.; Zadnik Vesna
    Overview of main mechanisms involved in social disparities in cancer incidence and prognosis
    2021 ►
  3. Allemani Claudia; Coleman Michel P.; Zadnik Vesna; Launoy Guy; Minicozzi Pamela
    Disparities in cancer survival in adults in Europe
    2021 ►
  4. Launoy Guy; Zadnik Vesna; Coleman Michel P.
    Social inequities in cancer
    2021 ►
  5. Mullins Niamh; Kang JooEun; Campos Adrian I.; Coleman Jonathan R.I.; Tsermpini Evangelia Erini
    Dissecting the shared genetic architecture of suicide attempt, psychiatric disorders, and known risk factors
    2022 ►
  6. Launoy Guy; Zadnik Vesna; Coleman Michel P.
    Social environment and cancer in Europe
    2021 ►
  7. Albreht Tit; McKee Martin; Alexe Delia-Marina; Coleman Michel P.; Martin-Moreno Jose M.
    Making progress against cancer in Europe in 2008
    2008 ►
  8. Gouveia Joaquim; Coleman Michel P.; Haward Robert; Zanetti Roberto; Hakama Matti; Borras Josep Maria; Primic-Žakelj Maja; De Koning Harry J.; Travado Luzia
    Improving cancer control in the European Union
    2008 ►
  9. Coleman Michel P; Rachet Bernard; Pohar-Perme Maja; Stare Janez
    Rebuttal to editorial saying cancer survival statistics are misleading: UK cancer survival statistics
    2011 ►
  10. Pajk Bojana; Čufer Tanja; Canney Peter; Ellis Paul; Cameron David; Blot Emmanuel; Vermorken Jan; Coleman Robert; Marreaud Sandrine; Bogaerts Jan
    Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from EORTC 10001 randomized phase II trial
    2008 ►
  11. Albreht Tit; McKee Martin; Alexe Delia-Marina; Coleman Michel P; Martin-Moreno Jose M
    Making progress against cancer
    2008 ►
  12. Alexe Delia-Marina; Albreht Tit; McKee Martin; Coleman Michel P
    Responding to the challenge of cancer in Europe
    2008 ►
  13. Coleman Michel P.; Alexe Delia-Marina; Albreht Tit; McKee Martin
    Responding to the challenge of cancer in Europe
    2008 ►
  14. Bottomley Andrew; Biganzoli Laura; Čufer Tanja; Coleman Robert E; Coens Cornel; Efficace Fabio; Calvert Hilary Allan; Gamucci Teresa; Twelves Chris; Fargeot Pierre; Piccart Martine
    Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European organization for research and treatment of cancer breast cancer group, Investigational drug branch for breast cancer and the New drug development group study
    2004 ►
  15. Paridaens R; Dyczka J; Rutgers EJT; Coleman R; Čufer T; Jassem J; Nortier JRW; Morales L; Mattiacci MR; Therasse P; Gasthuisberg UZ
    Postoperative adjuvant chemotherapy folowed by adjuvant tamoxifen versus nil for patients with operable breast cancer. First results of a randomized phase III trial EORTC 10901
    2004 ►
  16. Atalay G; Biganzoli L; Renard F; Paridaens R; Čufer T; Coleman R; Calvert AH; Gamucci T; Minisini A; Therasse P
    Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials
    2003 ►
  17. Eržen Mojca; Branca Margherita; Syrjaenen Kari; Coleman Dulcie V
    The Pap test procedure, quality assurance and continuous quality improvement in laboratories participating in cervical cancer screening: presentation of the items produced by Leonardo da Vinci Cytotrain 2000 project of Eurpean union
    2003 ►
  18. Biganzoli Laura; Čufer Tanja; Bruning Peter; Coleman Robert E; Duchateau Luc; Rapoport Bernardo; Nooij Marianne; Delhaye Francois; Miles D; Sulkes Aaron
    Doxorubicin-paclitaxel: a safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European organization for research and treatment of cancer multicenter trial
    2003 ►
  19. Eržen Mojca; Branca Margherita; Syrjaenen Kari; Coleman Dulcie V
    The PAP test procedure, quality assurance and continuous quality improvement in laboratories participating in cervical cancer screening. Presentation of the items produced by Leonardo da Vinci 2000 project of European union
    2003 ►
  20. Micheli A; Mugno E; Krogh V; Quinn MJ; Coleman M; Hakulinen T; Gatta G; Berrino F; Capocaccia R; Pompe-Kirn V
    Cancer prevalence in European registry areas
    2002 ►
  21. Biganzoli L; Čufer T; Bruning P; Coleman R; Duchateau L; Calvert AH; Gamucci T; Twelves C; Fargeot P; Epelbaum R; Lohrisch C; Piccart MJ
    Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European organization for research and treatment of cancer 10961 multicenter phase III trial
    2002 ►
  22. Sant M; Capocaccia R; Coleman MP; Berrino F; Gatta G; Micheli A; Verdecchia A; Faivre J; Hakulinen T; Pompe-Kirn V
    Cancer survival increases in Europe, but international differences remain wide
    2001 ►
  23. Gatta G; Luksch R; Coleman MP; Corazziari I; Pompe-Kirn V
    Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study
    2001 ►
  24. Biganzoli L; Čufer T; Bruning P; Coleman R; Calvert H; Gamucci T; Twelves C; di Paola E Donato; Duchateau L; Yague C
    Doxorubicin (A) / Taxol (T) versus doxorubicin /cyclophosphamide (C) as first line chemotherapy in metasttaic breast cancer (MBC): a phase III study
    2000 ►
  25. Forman D; Coleman M; De Backer G; Elder J; Moller H; Cayolla da Motta L; Roy P; Abid L; Tjonneland A; Primic-Žakelj M
    O6-methylguanine in blood leukocyte DNA: an association with the geographic prevalence of gastric cancer and with low levels of serum pepsinogen A, a marker of servere chronic atrophic gastritis
    1994 ►
  26. Webb PM; Hengels KJ; Moller H; Newell DG; Palli D; Elder JB; Coleman MP; de Backer G; Forman D; Primic-Žakelj M
    The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates
    1994 ►
  27. Forman D; Coleman M; de Backer G; Elder J; Moller H; Cayolla da Motta L; Roy P; Abid L; Primic-Žakelj M; Potočnik M
    Geographic correlation of biological risk factors with gastritis and gastric cancer
    1994 ►
  28. Forman D; Coleman M; de Backer G; Elder J; Moller H; Cayolla da Motta L; Roy P; Abid L; Primic-Žakelj M; Potočnik M
    An international association between Helicobacter pylori infection and gastric cancer
    1993 ►
  29. Coleman MP; Bell CMJ; Taylor H-L; Primic-žakelj M
    Leukaemia and residence near electricity transmission equipment: a case-control study
    1989 ►
  30. Kaldor JM; Day NE; Band P; Choi NW; Clarke EA; Coleman MP; Hakama M; Koch M; Pompe-Kirn V; Prior P
    Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries
    1987 ►
  31. Coleman SY; Morley AR; Appleton DR
    Computer re-sectioning of 3-dimensional reconstructions of serial sections
    1988 ►

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics